How do you pay?

How to pay the least

Ask for the cash price

Udenyca

Udenyca is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Udenyca’s cash price, and one or two other pharmacies too.
  2. Udenyca’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameUdenyca
Authorized genericpegfilgrastim-cbqv
Regular genericpegfilgrastim-cbqv
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Udenyca?
The original
–
–

Brand nameThe maker’s card

AccordCares Co-Pay Program

Savings card from Accord BioPharma

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a treatment

The card takes up to $15,000 a year off your co-pay.

Sign up on udenyca.com 

Or call 1-844-483-3692.

In the maker’s words

“Eligible patients may pay as little as $0 co-pay per UDENYCA treatment…”

From the maker’s offer on udenyca.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Udenyca itself, from the same company, sold without the brand name, and usually for less. For now Udenyca is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Udenyca is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

UDENYCA is a leukocyte growth factor indicated to

  • Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
  • Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Subsyndrome of Acute Radiation Syndrome).

Limitations of Use

UDENYCA is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.

Source: the FDA label for Udenyca (Accord BioPharma, Inc.), April 23, 2026. Full label on DailyMed 

Good to know